Clinical trial · Observational
Questionnaire and Fall Risk Assessment
A Cross-Sectional Study of the Predictability of a Questionnaire About Difficulty in Climbing Up or Down Stairs in Objective Measures of Functional Status in Elderly Patients With Prostate Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this research study is to learn if your answers to questions during an interview can help researchers predict how well you function physically and if you are at a high risk for falls. Primary Objectives: -To determine how accurately a simple questionnaire can predict three objective measures of function in elderly patients with prostate cancer. Secondary Objectives: * To assess the correlations between three functional tests and the number of self-reported falls in elderly patients with prostate cancer. * To determine risk factors related to number of falls in elderly prostate cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Interview | Behavioral | — | UNRESOLVED |
| Physical Function Tests | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Questionnaire + Fall Risk Assessment
- description
- Physical Function Interview + Physical Function Tests + Symptom Assessment Interview
- interventionNames
- Behavioral: Interview
- Other: Physical Function Tests
Primary outcomes (1)
- measure
- Number Patient Falls + Activity Limitations Using Functional Tests
- timeFrame
- 45 minutes total to complete during already-scheduled clinic visit
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients must have the ability to understand and willingness to sign a written informed consent document. 2. Patients must be able to ambulate with or without an assistive device, without assistance from a person. 3. Patients must be 65 years old or older. 4. Patients must have a diagnosis of prostate cancer 5. Patients must have received androgen deprivation therapy (ADT) for their prostate cancer for at least 3 months and were responding to treatment as determined by prostate-specific antigen criteria. 6. Patients have received chemotherapy within last month. 7. Patients must speak English. Exclusion Criteria: 1. Patients who decline to participate or who are determined incapable of completing the study. 2. Active Central Nervous System (CNS) disease such as clinically-evident CNS metastases or leptomeningeal disease, dementia, or encephalopathy (per treating physician's assessment).
References
Publications (0)
Data not yet available